Search results for " CELL CARCINOMA"

showing 10 items of 477 documents

Comment On: Study on the Effects of Allitride and its Mechanisms on Renal Cell Carcinoma in Vitro

2011

Renal cell carcinomabusiness.industryCancer researchmedicineGeneral Medicinemedicine.diseasebusinessIn vitroUrologia Journal
researchProduct

Imperative and Elective Indications for Nephron-Sparing Surgery for Renal Tumors: Long-Term Oncological Follow-Up

2010

INTRODUCTION: Nephron-sparing surgery (NSS) is mandatory for patients with renal tumors in both kidneys or in a solitary kidney in order to preserve renal function (imperative indication). NSS has also become the gold standard (elective indication) for small unilateral renal tumors (< 4 cm) with a normal contralateral kidney. We report the oncological long-term follow-up of NSS of our own series and discuss the results of the current literature. PATIENTS AND METHODS: From 1979 until 2006, a total of 851 patients was treated at our institu-tion by NSS. The mean tumor diameter was 3 cm (0.5-11 cm) for elective cases and 4.2 cm (1.2-11 cm) for imperative cases. The median follow-up for electiv…

Reoperationmedicine.medical_specialtyUrologySolitary kidneyRenal functionNephrectomyDisease-Free SurvivalNeoplasms Multiple PrimaryPostoperative ComplicationsRenal cell carcinomamedicineHumansCarcinoma Renal CellRetrospective StudiesTumor sizebusiness.industryGold standardNephronsmedicine.diseaseKidney NeoplasmsSurgeryElective Surgical ProceduresKidney Failure ChronicChronic renal failureBoth kidneysNephron sparing surgeryNeoplasm Recurrence LocalbusinessFollow-Up StudiesAktuelle Urologie
researchProduct

Retroperitoneal Squamous Cell Carcinoma Involving the Pelvic Side Wall Arising from Endometriosis: A Case Report

2022

&lt;b&gt;&lt;i&gt;Introduction:&lt;/i&gt;&lt;/b&gt; Squamous cell carcinoma (SCC) arising from endometriosis is very rare. Moreover, endometriosis located on the pelvic side wall is uncommon, while its cancerization is quite unusual. We herein report the first case of retroperitoneal SCC arising from endometriosis. &lt;b&gt;&lt;i&gt;Case Presentation:&lt;/i&gt;&lt;/b&gt; A case of a 52-year-old woman with retroperitoneal pararectal right mass is presented. The pelvic magnetic resonance imaging showed a retroperitoneal tumor extended to the right pelvic side wall. The neuropelveological examination completed the preoperative assessment, showing a right-sided sciatica and overactive bladder s…

Reproductive MedicineSquamous cell carcinomaEndometriosisObstetrics and GynecologyGynecologic and Obstetric Investigation
researchProduct

Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer

2016

Background: Trimodality bladder preservation therapy (BPT) in muscle invasive bladder cancer (MIBC) includes a maximal transurethral resection followed by concurrent chemoradiotherapy as an alternative to radical cystectomy (RC) in appropriately selected patients, or as a treatment option in non-cystectomy candidates. Several chemotherapy regimens can be used in BPT, but little is known about current practice patterns. Objective: To describe utilization patterns of BPT and associated survival outcomes in MIBC. Methods: Data were collected from the Retrospective International Study of Cancers of the Urothelial Tract (RISC), a database of 3,024 consecutive patients from 29 international acade…

Research ReportOncologymedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrologyUrologychemoradiotherapyCystectomy03 medical and health scienceschemistry.chemical_compoundTransitional cell carcinomacystectomy0302 clinical medicineInternal medicinemedicineBladder cancerPerformance statusbusiness.industrymedicine.diseaseCarboplatinGemcitabine3. Good healthRegimenTransitional cell carcinomaOncologychemistrycomparative effectiveness research030220 oncology & carcinogenesisbusinessChemoradiotherapymedicine.drugBladder Cancer
researchProduct

Intermittent Low-Dose IFN Gamma Treatment for Metastatic Renal Cell Carcinoma: Analysis of Factors Predicting Clinical Response and Long-Term Survival

1995

Background: Objective tumor remissions are induced by a variety of immunomodulating agents in a minority of patients suffering from metastasizing renal cell carcinoma. The results of different clinical studies, however, varied greatly for each of these treatment modalities. In order to elucidate potential causes for this variability and to further study the long-term results of intermittent low-dose IFN gamma therapy in patients with advanced renal cell cancer (RCC) we retrospectively analyzed factors predicting clinical response and long-term survival of 121 patients. Material and Methods: We retrospectively analyzed the clinical results of 5 phase II studies treating 121 patients with int…

Response rate (survey)OncologyCancer Researchmedicine.medical_specialtybusiness.industryLow doseWidespread DiseaseHematologyDiseasemedicine.diseaseOncologyRenal cell carcinomaInternal medicineLong term survivalImmunologymedicineLymphbusinessIfn gammaOncology Research and Treatment
researchProduct

Differentiation of seborrheic keratosis from basal cell carcinoma, nevi and melanoma by RGB autofluorescence imaging

2018

A clinical trial on the autofluorescence imaging of skin lesions comprising 16 dermatologically confirmed pigmented nevi, 15 seborrheic keratosis, 2 dysplastic nevi, histologically confirmed 17 basal cell carcinomas and 1 melanoma was performed. The autofluorescence spatial properties of the skin lesions were acquired by smartphone RGB camera under 405 nm LED excitation. The diagnostic criterion is based on the calculation of the mean autofluorescence intensity of the examined lesion in the spectral range of 515 nm–700 nm. The proposed methodology is able to differentiate seborrheic keratosis from basal cell carcinoma, pigmented nevi and melanoma. The sensitivity and specificity of the prop…

Seborrheic keratosisPathologymedicine.medical_specialty01 natural sciencesArticle010309 opticsLesion030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine0103 physical sciencesmedicinePigmented NevusBasal cellBasal cell carcinomaneoplasmsintegumentary systembusiness.industryMelanomamedicine.diseaseAtomic and Molecular Physics and OpticsAutofluorescencemedicine.symptomSkin lesionbusinessBiotechnology
researchProduct

A method for skin malformation classification by combining multispectral and skin autofluorescence imaging

2018

As the incidence of skin cancer is still increasing worldwide, there is a high demand for early, non-invasive and inexpensive skin lesion diagnostics. In this article we describe and combine two skin imaging methods: skin autofluorescence (AF) and multispectral criterion p’. To develop this method, we used custom made prototype with 405 nm, 526 nm, 663 nm and 964 nm LED illuminations, perpendicular positioned linear polarizers, 515 nm filter and IDS camera. Our aim is to develop a skin lesion diagnostic device for primary care physicians who do not have experience in dermatology or skin oncology. In this study we included such common benign lesion groups as seborrheic keratosis, hyperkerato…

Seborrheic keratosismedicine.medical_specialtyintegumentary systembusiness.industryMelanomaHyperkeratosisPrimary careBenign lesionSkin autofluorescencemedicine.diseaseDermatologymedicineBasal cell carcinomaSkin cancerbusinessBiophotonics: Photonic Solutions for Better Health Care VI
researchProduct

Skin cancer screening – better safe than sorry

2020

Skin cancer is the most common type of cancers. In Latvia, on average there are approximately 200 new melanoma and 1300 non-melanoma cancer cases per year. Non-melanoma cancers are: Basal Cell Carcinoma, Squamous Cell Carcinoma and others. It is essential to discover skin cancer at an early stage when it is treatable. For this reason, a reliable, non-invasive and quantitative skin cancer screening method is necessary in order to discover skin cancer as early as possible and to help physicians such as general practitioners and dermatologists assign patients to the best treatment as soon as possible. In this article, the current skin cancer incidence as well as the screening situation in Latv…

Seborrheic keratosismedicine.medical_specialtymultispectralnon-invasive01 natural sciences010309 opticslcsh:Social Sciences03 medical and health sciences0103 physical sciencesmedicinemelanomadiagnosticsBasal cell carcinomaStage (cooking)030304 developmental biology0303 health sciencesSkin cancer screeningintegumentary systemskin cancerbusiness.industryIncidence (epidemiology)MelanomascreeningCancerimagingmedicine.diseaseDermatologylcsh:HSkin cancerbusinessSHS Web of Conferences
researchProduct

ANP differentiates between primary Submandibular Gland Squamous Cell Carcinoma and Oral Squamous Cell Carcinoma: Preliminary data

2021

The natriuretic peptide system consists of three ligands, Atrial Natriuretic Peptide (ANP), Brain Natriuretic peptide (BNP) and C-type Natriuretic peptide (CNP), and three natriuretic peptide receptors (NPR’s), NPRA, NPRB and NPRC. We investigated the expression levels of NPPA (encoding ANP) and NPR1 (encoding NPRA, the main receptor for ANP) in primary benign (pleomorphic adenoma) and malignant (squamous cell carcinoma, SCC) submandibular salivary gland (SMG) tumors, as well as in primary oral squamous cell carcinoma (OSCC). We found that the NPPA and NPR1 expression levels were significantly different in SMG SCC versus OSCC, exhibiting a significant increase in NPPA and absence of NPR1 ex…

Settore BIO/17 - IstologiaOral squamous cell carcinomaAtrial natriuretic peptide ANPNPPANatriuretic peptide receptor A NPRASubmandibular gland squamous cell carcinomaSubmandibular gland pleomorphic adenoma.
researchProduct

TGF-&beta;/VEGF-A Genetic Variants Interplay in Genetic Susceptibility to Non-Melanocytic Skin Cancer

2022

Differential genetically determined expression of transforming growth factor-&beta; (TGF-&beta; pathway and of vascular endothelial growth factor-A (VEGF-A) might modulate the molecular &ldquo;milieu&rdquo; involved in the etio-pathogenesis of non-melanoma skin cancer (NMSC). We have evaluated the frequency of some functionally relevant SNPs of TGF-&beta; and VEGF-A genes in 70 NMSC patients and 161 healthy controls, typed for TGF-&beta;1 rs1800471, TGF-&beta;2 rs900, TGF-&beta;R1 rs334348 and rs334349, TGF-&beta;R2 rs4522809 and VEGF-A rs3025039 SNPs. TGF-&beta;R2 rs1800629G allele and related genotypes were found to be associated with a possible protective role against NMSC, whereas VEGF-…

Settore MED/04 - Patologia GeneraleVEGF-A geners1800629<i>TGF-β receptor genes</i>; <i>rs1800629</i>; <i>VEGF-A gene</i>; <i>rs3025039</i>; non melanocytic skin cancer; skin basal cell carcinoma; skin squamous cell carcinoma; genetic susceptibilityTGF-β receptor geneGeneticsskin basal cell carcinomaskin squamous cell carcinomaSettore MED/05 - Patologia Clinicanon melanocytic skin cancerGenetics (clinical)genetic susceptibilityrs3025039Genes; Volume 13; Issue 7; Pages: 1235
researchProduct